Date | Company | Event | Description | Result |
---|---|---|---|---|
Akebia Therapeutics | Phase 2 | Vadadustat, Anemia related to chronic kidney disease | Success | |
Tetraphase Pharmaceuticals | Phase 3 | Eravacycline, Complicated urinary tract infections | Failure | |
Flexion Therapeutics | PHASE 2B | FX006, osteoarthritis | Failure | |
Trevena | Phase 2b | TRV-130, Painkiller | Success |